These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 15181573

  • 1. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages.
    Risso MG, Garbarino GB, Mocetti E, Campetella O, Gonzalez Cappa SM, Buscaglia CA, Leguizamon MS.
    J Infect Dis; 2004 Jun 15; 189(12):2250-9. PubMed ID: 15181573
    [Abstract] [Full Text] [Related]

  • 2. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections.
    Risso MG, Pitcovsky TA, Caccuri RL, Campetella O, Leguizamón MS.
    Parasitology; 2007 Apr 15; 134(Pt 4):503-10. PubMed ID: 17166319
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH, De Vusser K, Laroy W, Daurelio L, Nocito AL, Revelli S, Contreras R.
    Vaccine; 2008 May 02; 26(19):2322-34. PubMed ID: 18403070
    [Abstract] [Full Text] [Related]

  • 5. Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs.
    Carneiro CM, Martins-Filho OA, Reis AB, Veloso VM, Araújo FM, Bahia MT, de Lana M, Machado-Coelho GL, Gazzinelli G, Correa-Oliveira R, Tafuri WL.
    Acta Trop; 2007 Feb 02; 101(2):120-9. PubMed ID: 17296162
    [Abstract] [Full Text] [Related]

  • 6. Superinfections with genetically characterized Trypanosoma cruzi clones did not aggravate morbidity and mortality in BALB/c mice.
    Lauria-Pires L, Teixeira AR.
    J Parasitol; 1997 Oct 02; 83(5):819-24. PubMed ID: 9379284
    [Abstract] [Full Text] [Related]

  • 7. Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes.
    Duthie MS, Cetron MS, Van Voorhis WC, Kahn SJ.
    Acta Trop; 2005 Mar 02; 93(3):317-29. PubMed ID: 15725381
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular and biological characterization of Trypanosoma cruzi strains isolated from children from Jequitinhonha Valley, State of Minas Gerais, Brazil.
    Silva JC, Assis GF, Oliveira MT, Valadares HM, Valle IF, Paiva NC, Martins HR, Lana Md.
    Rev Soc Bras Med Trop; 2013 Mar 02; 46(4):433-40. PubMed ID: 23982097
    [Abstract] [Full Text] [Related]

  • 11. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex.
    Mucci J, Hidalgo A, Mocetti E, Argibay PF, Leguizamon MS, Campetella O.
    Proc Natl Acad Sci U S A; 2002 Mar 19; 99(6):3896-901. PubMed ID: 11891302
    [Abstract] [Full Text] [Related]

  • 12. Predominance of lineage I among Trypanosoma cruzi isolates from Venezuelan patients with different clinical profiles of acute Chagas' disease.
    Añez N, Crisante G, da Silva FM, Rojas A, Carrasco H, Umezawa ES, Stolf AM, Ramírez JL, Teixeira MM.
    Trop Med Int Health; 2004 Dec 19; 9(12):1319-26. PubMed ID: 15598264
    [Abstract] [Full Text] [Related]

  • 13. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
    Covarrubias C, Cortez M, Ferreira D, Yoshida N.
    Int J Parasitol; 2007 Dec 19; 37(14):1609-16. PubMed ID: 17640647
    [Abstract] [Full Text] [Related]

  • 14. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA, Claser C, de Alencar BC, Tzelepis F, de Vasconcelos JR, de Oliveira G, Silvério JC, Machado AV, Lannes-Vieira J, Bruna-Romero O, Gazzinelli RT, dos Santos RR, Soares MB, Rodrigues MM.
    Vaccine; 2009 Sep 18; 27(41):5644-53. PubMed ID: 19635607
    [Abstract] [Full Text] [Related]

  • 15. Evolution of infection in mice inoculated by the oral route with different developmental forms of Trypanosoma cruzi I and II.
    Dias GB, Gruendling AP, Araújo SM, Gomes ML, Toledo MJ.
    Exp Parasitol; 2013 Nov 18; 135(3):511-7. PubMed ID: 23994765
    [Abstract] [Full Text] [Related]

  • 16. T rypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease.
    Dc-Rubin SS, Schenkman S.
    Cell Microbiol; 2012 Oct 18; 14(10):1522-30. PubMed ID: 22747789
    [Abstract] [Full Text] [Related]

  • 17. Phospholipase A1: a novel virulence factor in Trypanosoma cruzi.
    Belaunzarán ML, Wilkowsky SE, Lammel EM, Giménez G, Bott E, Barbieri MA, de Isola EL.
    Mol Biochem Parasitol; 2013 Feb 18; 187(2):77-86. PubMed ID: 23275096
    [Abstract] [Full Text] [Related]

  • 18. Trypanosoma cruzi: infectivity modulation of a clone after passages through different hosts.
    Pérez Brandán C, Padilla AM, Diosque P, Basombrío MA.
    Exp Parasitol; 2006 Oct 18; 114(2):89-93. PubMed ID: 16564526
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of cell invasion by Trypanosoma cruzi: importance of sialidase activity.
    de Titto EH, Araujo FG.
    Acta Trop; 1987 Sep 18; 44(3):273-82. PubMed ID: 2892363
    [Abstract] [Full Text] [Related]

  • 20. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
    Solana ME, Alba Soto CD, Fernández MC, Poncini CV, Postan M, González Cappa SM.
    Parasitology; 2009 May 18; 136(6):627-39. PubMed ID: 19366478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.